Abstract:As an important biomarker for early Alzheimer’s disease (AD) diagnostics and a valuable therapeutic target, amyloid β peptide (Aβ) in blood has attracted extensive attention concerning its detection and monitoring. The tough challenges for monitoring subtle changes of Aβ in blood are low expression and high interference from environmental factors. Here, we constructed a ratiometric sensor based on dual-emission luminescent lanthanide metal–organic coordination polymer (DE-LMOCP) as fluorescence probe for simple, sensitive and accurate detection of Aβ. The DE-LMOCP (luminol-Tb-GMP-Cu) fluorescent probe was composed of terbium ion(Tb3+) as the center metal ions, cupric ion(Cu2+) as a cofactor for Tb3+ fluorescence silence, guanine monophosphate (GMP) as a bridging ligand can strengthen the fluorescence of Tb3+, and luminol as an auxiliary ligand. In the DE-LMOCP fluorescent probe, the fluorescence of the GMP-Tb is quite weak because the existing cofactor Cu2+ prevents the energy transfer of intramolecular between GMP and Tb3+ and results in the quench of GMP-Tb fluorescence. The fluorescence of luminol acts as inner reference. In the presence of Aβ, the high binding affinity of Aβ for Cu2+ causes a remarkable emission enhancement of GMP-Tb and suppresses the quenching effect. However, the fluorescence emission of luminol remains constant as inner reference. Hence, sensitive and accurate determination of Aβ were performed by the ratio of the fluorescence of luminol (F430) to the Tb3+(F547). With this ratiometric probe, Aβ was determined with sensitivity down to 20 pM. Moreover, the ratiometric probe was successfully used to the detection of Aβ in human plasma with satisfactory results due to its capability to eliminate auto-fluorescence. Significantly, it exhibited sound specificity and selectivity to recognize Aβ1−40, and successfully applied to visual detection of Aβ, which validates the potential on-site application. Given the analytical characteristics with high sensitivity, specificity, and accuracy, the ratiometric fluorescence sensor may have great potential in applications of Aβ1−40 detection and the early diagnosis of Alzheimer’s disease, as well as point-of-care tests.

Two-in-one Polydopamine Nanospheres for Fluorescent Determination of Beta-Amyloid Oligomers and Inhibition of Beta-Amyloid Aggregation

A Novel Viscosity Sensitive Hemicyanine Fluorescent Dye for Real-Time Imaging of Amyloid-Β Aggregation

Fluorescent Peptide Nanoparticles to Monitor Aβ Oligomers

A Ratiometric Fluorescent Conjugated Oligomer for Amyloid Β Recognition, Aggregation Inhibition, and Detoxification.

Design of Self-Assembled Nanoparticles As a Potent Inhibitor and Fluorescent Probe for Β-Amyloid Fibrillization.

Fluorescent Peptide Nanoparticles to Detect Amyloid-Beta Aggregation in Cerebrospinal Fluid and Serum for Alzheimer's Disease Diagnosis and Progression Monitoring

Visual and Fluorescent Assays for Selective Detection of Beta-Amyloid Oligomers Based on the Inner Filter Effect of Gold Nanoparticles on the Fluorescence of CdTe Quantum Dots.

A Conformationally-Locked P-Hydroxybenzylidene Imidazolinone Derivative for Detecting Aβ42 Aggregation

Chemical Fluorescent Probe for Detection of Aβ Oligomers

Self‐Assembled Peptide–Polyoxometalate Hybrid Nanospheres: Two in One Enhances Targeted Inhibition of Amyloid Β‐peptide Aggregation Associated with Alzheimer's Disease

Detection of Amyloid-Beta by Fmoc-KLVFF Self-Assembled Fluorescent Nanoparticles for Alzheimer’s Disease Diagnosis

Using Multifunctional Peptide Conjugated Au Nanorods for Monitoring β-amyloid Aggregation and Chemo-Photothermal Treatment of Alzheimer's Disease.

Glycopeptide Nanofiber Platform for Aβ-Sialic Acid Interaction Analysis and Highly Sensitive Detection of Aβ.

Efficient ratiometric fluorescence probe based on dual-emission luminescent lanthanide coordination polymer for amyloid β-peptide detection

Synthesis and in Vitro Evaluation of Novel Indanone Derivatives Targeting Β-Amyloid

Selective Amyloid Β Oligomer Assay Based on Abasic Site-Containing Molecular Beacon and Enzyme-Free Amplification.

Advances in development of fluorescent probes for detecting amyloid-β aggregates

An AIE-Active NIR Fluorescent Probe with Good Water Solubility for the Detection of Aβ1–42 Aggregates in Alzheimer’s Disease

A Turn-on Unlabeled Colorimetric Biosensor Based on Aptamer-Aunps Conjugates for Amyloid-Β Oligomer Detection

Amyloid-β Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation and in Vivo Imaging.

A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles.